FDA Investigator Amanda B Vega
Amanda B Vega has conducted inspections on 21 sites in 1 countries as of 18 May 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
21
Last Inspection Date:
18 May 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Amanda B Vega:
Amanda B Athey,
Angela E Glenn,
Ann Marie Karnick,
Ashley B Jelonek,
Barbara T Carmichael,
Brandon L Mariner,
Brentley S Collins,
Brian S Keefer,
Cara M Minelli,
Carl E Lovrich,
Carrie L Doupnik,
Charles D Boison,
Colleen M Aspinwall,
Colleen M Damon,
Cynthia L Rakestraw,
Daniel J Mechenbier,
Dawn D Aiello,
Erica L Nicoll,
Erika M Wilkerson,
Holly M Scott,
Ivan E Reyes,
James T Mccoy,
Jana L Caylor,
Jennifer C Adams,
Jennifer C Johnson,
Joan A Loreng,
John M Gusto,
Jolanna A Norton,
Joseph W Matthews,
Judy Ellen Ciaraldi,
Justin H Price,
Kimberly A Dux,
Kish Bolden,
La Tasham Gunter,
Laurie A Haxel,
LCDR Margaret Edi Gennaro,
Lee Terry Moore,
Leon L Law,
Linda S Mattingly,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Lundy H Patrick,
Lura D Baquero,
Lura D Kelly,
Madelyn Renteria,
Margaret Torres Vazquez,
Marion W Nadeau,
Marjorie L Davis,
Mary R Kirker,
Matthew J Gretkierewicz,
Melissa D Kalik,
Michael J Diskin,
Michele M Falchek,
Mizanne E Lewis,
Nancy L Meade,
Nerizza B Guerin,
Nina D Patel,
Patricia A Morrow,
Paul L Figarole, Jr,
Richard J Bashay,
Ronnie E Jackson,
Samantha J Pinizzotto, D V M,
Shavon L Square,
Sherry L Secrist, BLT DO,
Shusheen A Alexander,
Stacey F Rivette,
Susan M Miller,
Susan M North,
Tamika E Allen, RN,
Tania E Vizcaino,
Traci M Armand,
Travis R Hunt,
Uruaku A Obasi,
Valerie Jgrecek Trinh,
Wanda Y Fields,
Wanda Y Honeyblue
Amanda B Vega's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2019 | FDA 483 | Quest Diagnostics Nichols Institute - Form 483, 2019-09-23 |
September, 2019 | EIR | Quest Diagnostics Nichols Institute - EIR, 2019-09-23 |
April, 2022 | FDA 483 | Suncoast Community Blood Bank Inc - Form 483, 2022-04-13 |
December, 2019 | FDA 483 | CSL Plasma - Form 483, 2019-12-06 |
December, 2021 | FDA 483 | BioLife Plasma Services LP - Form 483, 2021-12-16 |
August, 2019 | FDA 483 | Inova Health Care Services - Form 483, 2019-08-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more